GM1-Gangliosidosis Type III Associated Parkinsonism.

Kaiyrzhanov, Rauan; Guliyeva, Ulviyya; Gulieva, Sughra; Salayev, Kamran; Mursalova, Aytan; Allahyarova, Parvin; Ferla, Matteo P; Houlden, Henry

Kaiyrzhanov, Rauan; Guliyeva, Ulviyya; Gulieva, Sughra; Salayev, Kamran; Mursalova, Aytan; Allahyarova, Parvin; Ferla, Matteo P; Houlden, Henry.

Afiliación

Kaiyrzhanov R; Department of Neuromuscular Disorders University College London, Institute of Neurology London United Kingdom.
Guliyeva U; Department of Neurology South Kazakhstan Medical Academy Shymkent Kazakhstan.
Gulieva S; MediClub Hospital Baku Azerbaijan.
Salayev K; MediClub Hospital Baku Azerbaijan.
Mursalova A; Department of Neurology Azerbaijan Medical University Baku Azerbaijan.
Allahyarova P; Department of Neurology Azerbaijan Medical University Baku Azerbaijan.
Ferla MP; Department of Neurology Azerbaijan Medical University Baku Azerbaijan.
Houlden H; NIHR Oxford BRC Genomic Medicine, Wellcome Centre for Human Genetics University of Oxford Oxford United Kingdom.

Mov Disord Clin Pract ; 8(Suppl 1): S21-S23, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34514040

Palabras clave

GLB1; GM1gangliosidosis; dystonia; genetics; parkinsonism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google